Kim RB - Search Results

1

Impact of genetic variation in OATP transporters to drug disposition and response.

Gong IY, Kim RB. Gong IY, et al. Among authors: kim rb. Drug Metab Pharmacokinet. 2013;28(1):4-18. doi: 10.2133/dmpk.dmpk-12-rv-099. Epub 2012 Oct 9. Drug Metab Pharmacokinet. 2013. PMID: 23047721 Review.

2

Beyond CAR and PXR.

Dixit SG, Tirona RG, Kim RB. Dixit SG, et al. Among authors: kim rb. Curr Drug Metab. 2005 Aug;6(4):385-97. doi: 10.2174/1389200054633907. Curr Drug Metab. 2005. PMID: 16101576 Review.

3

Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).

Gradhand U, Kim RB. Gradhand U, et al. Among authors: kim rb. Drug Metab Rev. 2008;40(2):317-54. doi: 10.1080/03602530801952617. Drug Metab Rev. 2008. PMID: 18464048 Review.

4

In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice.

Yasuda K, Cline C, Lin YS, Scheib R, Ganguly S, Thirumaran RK, Chaudhry A, Kim RB, Schuetz EG. Yasuda K, et al. Among authors: kim rb. Drug Metab Dispos. 2015 Nov;43(11):1646-54. doi: 10.1124/dmd.115.065078. Epub 2015 Aug 17. Drug Metab Dispos. 2015. PMID: 26281846 Free PMC article.

5

Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling.

Posada MM, Bacon JA, Schneck KB, Tirona RG, Kim RB, Higgins JW, Pak YA, Hall SD, Hillgren KM. Posada MM, et al. Among authors: kim rb. Drug Metab Dispos. 2015 Mar;43(3):325-34. doi: 10.1124/dmd.114.059618. Epub 2014 Dec 12. Drug Metab Dispos. 2015. PMID: 25504564

6

Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.

Meyer zu Schwabedissen HE, Tirona RG, Yip CS, Ho RH, Kim RB. Meyer zu Schwabedissen HE, et al. Among authors: kim rb. Cancer Res. 2008 Nov 15;68(22):9338-47. doi: 10.1158/0008-5472.CAN-08-0265. Cancer Res. 2008. PMID: 19010908 Free PMC article.

7

Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1.

Medwid S, Li MMJ, Knauer MJ, Lin K, Mansell SE, Schmerk CL, Zhu C, Griffin KE, Yousif MD, Dresser GK, Schwarz UI, Kim RB, Tirona RG. Medwid S, et al. Among authors: kim rb. Drug Metab Dispos. 2019 Aug;47(8):832-842. doi: 10.1124/dmd.119.087619. Epub 2019 May 23. Drug Metab Dispos. 2019. PMID: 31123035

8

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB. Dresser GK, et al. Among authors: kim rb. Clin Pharmacol Ther. 2002 Jan;71(1):11-20. doi: 10.1067/mcp.2002.121152. Clin Pharmacol Ther. 2002. PMID: 11823753 Clinical Trial.

9

Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.

Dresser GK, Kim RB, Bailey DG. Dresser GK, et al. Among authors: kim rb. Clin Pharmacol Ther. 2005 Mar;77(3):170-7. doi: 10.1016/j.clpt.2004.10.005. Clin Pharmacol Ther. 2005. PMID: 15735611 Clinical Trial.

10

Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.

Zamek-Gliszczynski MJ, Taub ME, Chothe PP, Chu X, Giacomini KM, Kim RB, Ray AS, Stocker SL, Unadkat JD, Wittwer MB, Xia C, Yee SW, Zhang L, Zhang Y; International Transporter Consortium. Zamek-Gliszczynski MJ, et al. Among authors: kim rb. Clin Pharmacol Ther. 2018 Nov;104(5):890-899. doi: 10.1002/cpt.1112. Epub 2018 Aug 8. Clin Pharmacol Ther. 2018. PMID: 30091177 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results